Further analysis of the NF1 deletion-bearing tumours revealed significantly higher levels of active RAS, indicating that RAS signal transduction pathway dysregulation, through NF1 loss, may be responsible for driving malignancy in these cells. The gene discussed is NF1; the disease is neoplasm.